Siga Technologies (SIGA) Net Margin (2010 - 2025)
Siga Technologies' (SIGA) quarterly Net Margin came in at 242.97% in Q3 2025, down 25640.0% on a YoY basis from N/an in Q3 2024, and down 655.64% quarter-over-quarter from 43.73% in Q2 2025.
Powered by 
Analysis
Siga Technologies (SIGA) Net Margin (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Net Margin for 16 consecutive years, with 242.97% the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Net Margin fell 25640.0% year-over-year to 242.97%; the trailing twelve-month figure through Sep 2025 stood at 43.25% (down 607.0% YoY), and the FY2024 full-year result was 42.69%, down 596.0% from the prior year.
- Net Margin eased to 242.97% in Q3 2025 per SIGA's latest filing, from 43.73% in the prior quarter.
- Across five years, Net Margin topped out at 63.61% in Q4 2021 and bottomed at 242.97% in Q3 2025.
- Historically, Net Margin has averaged 4.26% across 5 years, with a median of 2.99% in 2021.
- The sharpest annual moves came in 2021 and 2025: Net Margin surged 30367 bps in 2021, then plunged 25640 bps in 2025.
- Over 5 years, Net Margin stood at 63.61% in 2021, then tumbled by 111 bps to 7.15% in 2022, then jumped by 968 bps to 62.03% in 2023, then fell by 9 bps to 56.17% in 2024, then tumbled by 533 bps to 242.97% in 2025.
- According to Business Quant data, Net Margin over the past three periods registered 242.97%, 43.73%, and 5.26% for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | 21.28% |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | -8.05% |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 22.65% |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -1.58% |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 2.96% |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 34.98% |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 42.51% |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -242.97% |
| Jun 30, 2025 | 43.73% |
| Mar 31, 2025 | -5.26% |
| Dec 31, 2024 | 56.17% |
| Sep 30, 2024 | 13.43% |
| Jun 30, 2024 | 8.24% |
| Mar 31, 2024 | 40.41% |
| Dec 31, 2023 | 62.03% |
| Sep 30, 2023 | -4.26% |
| Jun 30, 2023 | -48.92% |
| Mar 31, 2023 | -11.03% |
| Dec 31, 2022 | -7.15% |
| Sep 30, 2022 | 45.76% |
| Jun 30, 2022 | 11.92% |
| Mar 31, 2022 | -3.43% |
| Dec 31, 2021 | 63.61% |
| Sep 30, 2021 | -64.24% |
| Jun 30, 2021 | -2.99% |
| Mar 31, 2021 | -35.96% |
| Dec 31, 2020 | 53.44% |